{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-073072","form_type":"8-K","ticker":"LCTX","cik":"0000876343","company_name":"Lineage Cell Therapeutics, Inc.","filed_at":"2024-06-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:22.250027+00:00","generated_at":"2026-06-01T04:44:49.202923+00:00","sec_items":["5.03","5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Lineage Cell Therapeutics annual meeting: all 9 directors elected, auditor ratified, say-on-pay approved","bullets":["All nine director nominees elected with 89.8M-90.8M votes for and 1.5M-2.4M withheld.","Ratification of WithumSmithBrown as auditor passed: 128.6M for, 2.4M against.","Advisory say-on-pay approved: 87.8M for, 3.7M against, 0.7M abstentions.","Board amended bylaws effective June 11, 2024, updating advance notice and California code compliance.","Bylaw changes include Rule 14a-19 compliance requirement and electronic meeting provisions."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-073072","json":"https://secwatch.observer/filing/0000950170-24-073072.json","markdown":"https://secwatch.observer/filing/0000950170-24-073072.md","text":"https://secwatch.observer/filing/0000950170-24-073072.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/876343/000095017024073072/0000950170-24-073072-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/876343/000095017024073072/lctx-20240613.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T04:44:49.202923+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}